Tetrahydroberberine, an Isoquinoline Alkaloid Isolated from Corydalis Tuber, Enhances Gastrointestinal Motor Function
Authors:
- Ki Hyun KimKi Hyun Kim
- Kang Ro LeeKLKang Ro Lee
- Miwon SonMSMiwon Son
- Mirim JinMJMirim Jin
Open Access
- 1 September 2011
- journal article
- research article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 338 (3) , 917-924
Abstract
Because delayed gastric emptying and impaired gastric accommodation are regarded as pathophysiological mechanisms underlying functional dyspepsia (FD), prokinetics and fundic relaxants have been suggested as a new treatment for FD. We isolated tetrahydroberberine (THB), an isoquinoline alkaloid (5,8,13,13a-tetrahydro-9,10-dimethoxy-6H-benzo[g]-1,3-benzodioxolo[5,6-a]quinolizine) from Corydalis tuber, and found that it has micromolar affinity for dopamine D2 (pKi = 6.08) and 5-HT1A (pKi = 5.38) receptors but moderate to no affinity for other relevant serotonin receptors (i.e., 5-HT1B, 5-HT1D, 5-HT3, and 5-HT4; pKi < 5.00). Oral administration of THB not only resulted in significantly accelerated gastric emptying of normal rats in a bell-shaped relationship, with a maximal efficacy at a dose of 30 μg/kg, but also restored the delayed gastric emptying caused by apomorphine, which might be mediated by an antidopaminergic effect. Data from electromyography indicated enhanced motor function of the upper gastrointestinal tract by THB, which occurred through strengthening contractility and shortening the contraction interval. Furthermore, in rats stressed by repeated restraint, a significantly higher shift in the pressure-volume curve by THB (10 μg/kg, p < 0.05), which was inhibited by [O-methyl-3H]-N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide trihydrochloride (WAY-100635), a 5-HT1A antagonist, and Nω-nitro-l-arginine methyl ester, a nitric-oxide synthase inhibitor but not a vasoactive intestinal peptide antagonist, was observed. Oral administration of THB resulted in a drastic increase of gastric accommodation in Beagle dogs. Area under the volume versus time curve was increased significantly by THB (30 μg/kg, p < 0.01) and comparable with that of sumatriptan (3 mg/kg), a potent fundic relaxant. Taken together, our data suggested that THB, with D2 receptor antagonist and 5-HT1A receptor agonist properties, has significant potential as a therapeutic for treatment of FD.Keywords
This publication has 42 references indexed in Scilit:
- Review: Functional dyspepsiaTherapeutic Advances in Gastroenterology, 2010
- Synchronized gastric electrical stimulation improves vagotomy-induced impairment in gastric accommodation via the nitrergic pathway in dogsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2009
- 5‐HT4receptor agonists: similar but not the sameNeurogastroenterology & Motility, 2008
- A Placebo-Controlled Trial of Itopride in Functional DyspepsiaNew England Journal of Medicine, 2006
- Tegaserod, a 5‐HT 4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjectsAlimentary Pharmacology & Therapeutics, 2001
- Role of nitric oxide in fasting gastric fundus tone and in 5-HT1receptor-mediated relaxation of gastric fundusAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 1999
- The use of nitric oxide donors in pharmacological studiesNaunyn-Schmiedeberg's Archives of Pharmacology, 1998
- Analysis of the Ligand Binding Site of the 5-HT 3 Receptor Using Site Directed Mutagenesis: Importance of Glutamate 106Neuropharmacology, 1997
- Involvement of nitric oxide in the reflex relaxation of the stomach to accommodate food or fluidNature, 1991
- A novel water-soluble dopamine-2 antagonist with anticholinesterase activity in gastrointestinal motor activityGastroenterology, 1990